Modeling the effect of glucagon on endogenous glucose production in type 1 diabetes: On the role of glucagon receptor dynamics

被引:1
|
作者
Furio-Novejarque, Clara [1 ]
Sanz, Ricardo [1 ]
Ritschel, Tobias K. S. [2 ]
Reenberg, Asbjorn Thode [2 ]
Ranjan, Ajenthen G. [3 ,4 ]
Norgaard, Kirsten [3 ]
Diez, Jose-Luis [1 ,5 ]
Jorgensen, John Bagterp [2 ]
Bondia, Jorge [1 ,5 ]
机构
[1] Univ Politecn Valencia, Inst Univ Automat Informat Ind, C Cami Vera S-N, Valencia 46022, Spain
[2] Tech Univ Denmark, Dept Appl Math & Comp Sci, Anker Engelunds Vej 1, DK-2800 Lyngby, Denmark
[3] Steno Diabet Ctr Copenhagen, Borgmester Ib Juuls Vej 83, DK-2730 Herlev, Denmark
[4] Danish Diabet Acad, Sondre Blvd 29, DK-5000 Odense, Denmark
[5] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Ave Monforte de Lemos 3-5, Madrid 28029, Spain
关键词
Type; 1; diabetes; Modeling; Endogenous glucose production; Glucagon receptors; INDUCED MILD HYPOGLYCEMIA; INSULIN;
D O I
10.1016/j.compbiomed.2023.106605
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This paper validates a glucoregulatory model including glucagon receptors dynamics in the description of endogenous glucose production (EGP). A set of models from literature are selected for a head-to-head comparison in order to evaluate the role of glucagon receptors. Each EGP model is incorporated into an existing glucoregulatory model and validated using a set of clinical data, where both insulin and glucagon are administered. The parameters of each EGP model are identified in the same optimization problem, minimizing the root mean square error (RMSE) between the simulation and the clinical data. The results show that the RMSE for the proposed receptors-based EGP model was lower when compared to each of the considered models (Receptors approach: 7.13 +/- 1.71 mg/dl vs. 7.76 +/- 1.45 mg/dl (P = 0.066), 8.45 +/- 1.38 mg/dl (P = 0.011) and 8.99 +/- 1.62 mg/dl (P = 0.007)). This raises the possibility of considering glucagon receptors dynamics in type 1 diabetes simulators.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Effect of Glucagon on Nocturnal Rates of Endogenous Glucose Production in Type 2 Diabetes
    Basu, Ananda
    Zhai, Hualing
    Carter, Rickey
    Basu, Rita
    [J]. DIABETES, 2018, 67
  • [2] Effect of Glucose Concentrations on Hepatic Glucagon Sensitivity and Glucagon Clearance in Type 1 Diabetes
    Hinshaw, Ling
    Mallad, Ashwini
    Dalla Man, Chiara
    Cobelli, Claudio
    Basu, Rita
    Carter, Rickey
    Kudva, Yogish C.
    Basu, Ananda
    [J]. DIABETES, 2014, 63 : A61 - A61
  • [3] Evaluation of the Effect of Intranasal Glucagon on Endogenous Glucose Production
    Dash, Satya
    Xiao, Changting
    Koulajian, Khajag
    Lewis, Gary F.
    [J]. DIABETES, 2016, 65 : A483 - A483
  • [4] Analysis on the contribution of glucagon receptors to glucose dynamics in type 1 diabetes
    Furio-Novejarque, Clara
    Sala-Mira, Ivan
    Ranjan, Ajenthen G.
    Norgaard, Kirsten
    Diez, Jose-Luis
    Jorgensen, John Bagterp
    Bondia, Jorge
    [J]. IFAC JOURNAL OF SYSTEMS AND CONTROL, 2024, 29
  • [5] Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production
    Jun, Lucy S.
    Millican, Rohn L.
    Hawkins, Eric D.
    Konkol, Debra L.
    Showalter, Aaron D.
    Christe, Michael E.
    Michael, M. Dodson
    Sloop, Kyle W.
    [J]. DIABETES, 2015, 64 (03) : 819 - 827
  • [6] Effect of dapagliflozin, saxagliptin, and the combination of both on glucagon, endogenous glucose production (EGP) and glycerol in patients with type 2 diabetes
    Sach-Friedl, S.
    Augustin, T.
    Magnes, C.
    Ekardt, E.
    Eberl, A.
    Narath, S.
    Brunner, M.
    Korsatko, S.
    Svehlikova, E.
    Treiber, G.
    Pieber, T. R.
    [J]. DIABETOLOGIA, 2017, 60 : S412 - S412
  • [7] Exercise Effect on Endogenous Glucose Production in Type 1 Diabetes: A Modeling Analysis
    Romeres, Davide
    Schiavon, Michele
    Visentin, Roberto
    Basu, Ananda
    Cobelli, Claudio
    Basu, Rita
    Dalla, Man Chiara
    [J]. DIABETES, 2020, 69
  • [8] Modeling Glucagon Action in Patients With Type 1 Diabetes
    Emami, Ali
    El Youssef, Joseph
    Rabasa-Lhoret, Remi
    Pineau, Joelle
    Castle, Jessica R.
    Haidar, Ahmad
    [J]. IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2017, 21 (04) : 1163 - 1171
  • [9] Evidence Against a Role for Glucagon in the Increase of Hepatic Glucose Production and Plasma Glucose Levels in a Rodent Model of Type 1 Diabetes
    Meek, Thomas H.
    Matsen, Miles E.
    Fischer, Jonathan D.
    Taborsky, Gerald J., Jr.
    Schwartz, Michael W.
    Morton, Gregory J.
    [J]. DIABETES, 2013, 62 : A524 - A524
  • [10] Effects of glucagon in the control of endogenous glucose production in man
    Surmely, JF
    Schneiter, P
    Henry, S
    Paquot, N
    Jequier, E
    Tappy, L
    [J]. NUTRITION, 1999, 15 (04) : 267 - 273